Claret Asset Management’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $20.8M | Buy |
289,278
+1,385
| +0.5% | +$107K | 2.48% | 12 |
|
|
2025
Q4 | $22.8M | Sell |
287,893
-4,501
| -2% | -$355K | 2.65% | 11 |
|
|
2025
Q3 | $22M | Sell |
292,394
-3,994
| -1% | -$274K | 2.63% | 12 |
|
|
2025
Q2 | $20.4M | Sell |
296,388
-1,620
| -0.5% | -$106K | 2.65% | 12 |
|
|
2025
Q1 | $20.2M | Sell |
298,008
-3,735
| -1% | -$224K | 2.91% | 11 |
|
|
2024
Q4 | $13.5M | Buy |
301,743
+28,500
| +10% | +$1.6M | 2.14% | 14 |
|
|
2024
Q3 | $17.2M | Sell |
273,243
-2,586
| -0.9% | -$151K | 2.81% | 11 |
|
|
2024
Q2 | $16.3M | Sell |
275,829
-3,437
| -1% | -$215K | 2.9% | 10 |
|
|
2024
Q1 | $22.3M | Sell |
279,266
-1,008
| -0.4% | -$77K | 3.74% | 9 |
|
|
2023
Q4 | $22.1M | Buy |
280,274
+751
| +0.3% | +$53.5K | 3.96% | 8 |
|
|
2023
Q3 | $19.5M | Buy |
279,523
+16,361
| +6% | +$1.16M | 3.83% | 9 |
|
|
2023
Q2 | $18.2M | Buy |
263,162
+4,887
| +2% | +$348K | 3.55% | 9 |
|
|
2023
Q1 | $19.2M | Buy |
258,275
+42,590
| +20% | +$3.57M | 3.79% | 8 |
|
|
2022
Q4 | $20.1M | Buy |
215,685
+1,302
| +0.6% | +$126K | 4.44% | 5 |
|
|
2022
Q3 | $20.4M | Buy |
214,383
+1,801
| +0.8% | +$178K | 4.85% | 3 |
|
|
2022
Q2 | $19.7M | Buy |
212,582
+1,570
| +0.7% | +$153K | 4.25% | 5 |
|
|
2022
Q1 | $21.4M | Buy |
211,012
+3,046
| +1% | +$320K | 4.11% | 6 |
|
|
2021
Q4 | $21.5M | Sell |
207,966
-1,860
| -0.9% | -$172K | 3.97% | 6 |
|
|
2021
Q3 | $17.8M | Buy |
209,826
+1,408
| +0.7% | +$118K | 3.05% | 9 |
|
|
2021
Q2 | $17.4M | Buy |
208,418
+4,062
| +2% | +$333K | 2.85% | 9 |
|
|
2021
Q1 | $15.4M | Sell |
204,356
-2,518
| -1% | -$183K | 2.85% | 12 |
|
|
2020
Q4 | $14.1M | Sell |
206,874
-3,635
| -2% | -$236K | 2.79% | 12 |
|
|
2020
Q3 | $12.3M | Buy |
210,509
+33,618
| +19% | +$2.09M | 2.74% | 11 |
|
|
2020
Q2 | $11.5M | Buy |
176,891
+43,011
| +32% | +$2.71M | 2.72% | 11 |
|
|
2020
Q1 | $7.94M | Buy |
133,880
+2,881
| +2% | +$192K | 2.24% | 13 |
|
|
2019
Q4 | $9.73M | Buy |
130,999
+2,680
| +2% | +$188K | 1.87% | 15 |
|
|
2019
Q3 | $8.09M | Buy |
128,319
+4,397
| +4% | +$261K | 1.66% | 17 |
|
|
2019
Q2 | $6.75M | Buy |
123,922
+1,196
| +1% | +$64.4K | 1.4% | 18 |
|
|
2019
Q1 | $6.62M | Buy |
122,726
+2,327
| +2% | +$144K | 1.32% | 19 |
|
|
2018
Q4 | $7.89M | Sell |
120,399
-650
| -0.5% | -$48.5K | 1.75% | 15 |
|
|
2018
Q3 | $9.53M | Buy |
121,049
+658
| +0.5% | +$47K | 1.84% | 15 |
|
|
2018
Q2 | $7.75M | Buy |
120,391
+8,322
| +7% | +$548K | 1.58% | 17 |
|
|
2018
Q1 | $6.97M | Buy |
112,069
+29,933
| +36% | +$2.15M | 1.59% | 16 |
|
|
2017
Q4 | $5.96M | Buy |
+82,136
| New | +$5.97M | 1.3% | 25 |
|
Other funds holding CVS
VCM
VPM
Claret Asset Management's CVS Position: Q1 2026 in Review
Claret Asset Management increased its CVS Health (CVS) stake by 0.48% in Q1 2026, buying an estimated $107K and bringing the position to 289,278 shares worth $20.8M. The position accounts for 2.48% of the portfolio, ranked #12.
Claret Asset Management first reported a position in CVS in Q4 2017 and has held it in 34 quarters since. The position peaked at $22.8M in Q4 2025. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.
- Claret Asset Management held 289,278 shares of CVS Health worth $20.8M as of Q1 2026.
- Claret Asset Management bought 1,385 CVS Health shares in Q1 2026, an estimated $107K.
- CVS Health made up 2.48% of Claret Asset Management's portfolio in Q1 2026, its #12 holding.
- Claret Asset Management first reported a position in CVS Health in Q4 2017 and has held it in 34 quarters since.
- Claret Asset Management's CVS Health position peaked at $22.8M in Q4 2025.
- 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.
Based on Claret Asset Management's 13F filing for Q1 2026, filed 11 May 2026.